1-1 of 1
Jae-Hyun Park, DVM, PhD
Close
Sort by
Journal Articles

Treatment with the Novel TOPK Inhibitor OTS514 Exhibits Potent Anti-Myeloma Activity in Pre-Clinical Models

Andrew Stefka, MS, David Johnson, Shaun Rosebeck, PhD, Jae-Hyun Park, DVM, PhD, Yusuke Nakamura, MD, Andrzej J. Jakubowiak, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4415.
https://doi.org/10.1182/blood.V130.Suppl_1.4415.4415
Published: 2017